Express Scripts (ESRX) Tops Q2 EPS by 4c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St declines as oil prices, Treasury yields remain elevated
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Oppenheimer sees AI software winners as focus shifts to ROI
- Arm Holdings falls as CFO stock sale weighs on sentiment
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range
July 28, 2015 4:10 PM EDTST. LOUIS, July 28, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2015 second quarter net income attributable to Express Scripts stockholders of $600.1 million, or $0.88 per diluted share. Adjusted earnings per diluted share, as detailed in Table 4, were $1.44 for the second quarter. 1Â
"It is clear many companies across healthcare are validating the need for size and scale," said George Paz, Chairman and Chief Executive Officer. "But, what matters most is how that size and scale is leveraged. In our case, that means creating a business model fully aligned with... More
